Vacunación frente al neumococo en adultos mayores de 65 años

López Gobernado, Miguel; Pérez-Rubio, Alberto; Eiros Bouza, José María.
Aten. prim. (Barc., Ed. impr.) ; 52(10): 802-803, dic. 2020.
Artículo en Español | IBECS (España) | ID: ibc-199609

Documentos relacionados

  1. From individual to herd protection with pneumococcal vaccines: the contribution of the Cuban pneumococcal conjugate vaccine implementation strategy.
  2. Dynamic transmission models and economic evaluations of pneumococcal conjugate vaccines: a quality appraisal and limitations.
  3. Impact of pneumococcal conjugate vaccine on the prevention of invasive pneumococcal diseases.
  4. Pneumococcal (Pneumonia) Vaccines.
  5. Economic evaluation of universal 7-valent pneumococcal conjugate vaccination in Taiwan: a cost-effectiveness analysis.
  6. Cost-effectiveness analysis of adult pneumococcal conjugate vaccines for pneumococcal disease in Japan.
  7. An evaluation of emerging vaccines for childhood pneumococcal pneumonia.
  8. Health and economic impact of the pneumococcal conjugate vaccine in hindering antimicrobial resistance in China.
  9. Pneumococcal conjugate vaccine update.
  10. Potential cost-effectiveness of pneumococcal conjugate vaccine (PCV) in Turkey.